Skip to main content

Main menu

  • Home
  • Content
    • Current
      • JNMT Supplement
    • Ahead of print
    • Past Issues
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNMT
    • Information for Authors
    • Assignment of Copyright
    • AQARA Requirements
  • Info
    • Permissions
    • Continuing Education
    • Advertisers
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Editorial Contact
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNMT
    • JNM
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine Technology
  • SNMMI
    • JNMT
    • JNM
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine Technology

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNMT
    • Information for Authors
    • Assignment of Copyright
    • AQARA Requirements
  • Info
    • Permissions
    • Continuing Education
    • Advertisers
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Editorial Contact
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow SNMMI on Twitter
  • Visit SNMMI on Facebook
  • Join SNMMI on LinkedIn
  • Subscribe to JNMT RSS feeds

radionuclide therapy

  • α-Labeling of J591, an Antibody Targeting Prostate-Specific Membrane Antigen: The Technique and Considerations from the First Dedicated Production Lab at an Academic Institution in the United States
    You have access
    α-Labeling of J591, an Antibody Targeting Prostate-Specific Membrane Antigen: The Technique and Considerations from the First Dedicated Production Lab at an Academic Institution in the United States
    Kritika Subramanian, Judith Stangl-Kremser, Lady Sawoszczyk, Vasilios Avlonitis, Andrew Gernerd, Kyla Nixon, Michael Zgaljardic, Scott Tagawa, Neil Bander and Joseph R. Osborne
    Journal of Nuclear Medicine Technology April 25, 2023, jnmt.122.265166; DOI: https://doi.org/10.2967/jnmt.122.265166
  • You have access
    177Lu-PSMA Therapy
    Ephraim E. Parent, Bital Savir-Baruch, Isis W. Gayed, Frankis Almaguel, Bennett B. Chin, Austin R. Pantel, Evan Armstrong, Amanda Morley, Robin C. Ippisch and Robert R. Flavell
    Journal of Nuclear Medicine Technology September 1, 2022, 50 (3) 205-212; DOI: https://doi.org/10.2967/jnmt.122.263814
  • You have access
    Nuts and Bolts of 223Ra-Dichloride Therapy
    Erin Grady
    Journal of Nuclear Medicine Technology September 1, 2022, 50 (3) 215-221; DOI: https://doi.org/10.2967/jnmt.122.263812
  • Stability Matters: Radiochemical Stability of Therapeutic Radiopharmaceutical <sup>177</sup>Lu-PSMA I&amp;T
    You have access
    Stability Matters: Radiochemical Stability of Therapeutic Radiopharmaceutical 177Lu-PSMA I&T
    Madhusudan Vyas, Remy Lim, Jessica Fagan and Rudresh Chandrashekar
    Journal of Nuclear Medicine Technology September 1, 2022, 50 (3) 244-247; DOI: https://doi.org/10.2967/jnmt.121.262423
  • Estimation of Chest Wall Attenuation of <sup>123</sup>I Emissions in Substernal Goiter: A Phantom Study
    You have access
    Estimation of Chest Wall Attenuation of 123I Emissions in Substernal Goiter: A Phantom Study
    Matthew Alfano, John Weaver, Richard Mazurek and Alan Siegel
    Journal of Nuclear Medicine Technology September 1, 2021, 49 (3) 232-234; DOI: https://doi.org/10.2967/jnmt.120.260810
  • You have access
    Guidance on 177Lu-DOTATATE Peptide Receptor Radionuclide Therapy from the Experience of a Single Nuclear Medicine Division
    Amanda Abbott, Christopher G. Sakellis, Eric Andersen, Yuji Kuzuhara, Lauren Gilbert, Kelly Boyle, Matthew H. Kulke, Jennifer A. Chan, Heather A. Jacene and Annick D. Van den Abbeele
    Journal of Nuclear Medicine Technology September 1, 2018, 46 (3) 237-244; DOI: https://doi.org/10.2967/jnmt.118.209148
  • You have access
    Technical Advances in Image Guidance of Radionuclide Therapy
    Casper Beijst, Britt Kunnen, Marnix G.E.H. Lam and Hugo W.A.M. de Jong
    Journal of Nuclear Medicine Technology December 1, 2017, 45 (4) 272-279; DOI: https://doi.org/10.2967/jnmt.117.190991
  • You have access
    Release of Patients Containing Therapeutic Dosages of Iodine-131 from Hospitals
    James E. Carey, Thomas M. Kumpuris and Mark C. Wrobel
    Journal of Nuclear Medicine Technology September 1, 1995, 23 (3) 144-149;
  • You have access
    A Difficult Therapeutic Problem with a Nuclear Medicine Solution: A Case Report
    James Corley, Jeannie Yoder and George Burke
    Journal of Nuclear Medicine Technology September 1, 1995, 23 (3) 195-196;
  • You have access
    Performance and Responsibility Guidelines for the Nuclear Medicine Technologist
    Debra Higgins, Art Hall, Mickey Clarke, Laura Mayle and Aldona Montanaro-Sebal
    Journal of Nuclear Medicine Technology December 1, 1994, 22 (4) 255-260;
SNMMI

© 2023 Journal of Nuclear Medicine Technology

Powered by HighWire